The T1D Fund is an impact investment fund accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D). Launched in 2016, the T1D Fund is the first scaled venture fund established to catalyze the development of T1D cure-oriented therapies through equity investments. The Fund co-invests with venture capital and biopharma in support of early-stage companies pursuing disease modifying therapies and potential cures for T1D. A core element of our mission is to rapidly advance promising therapies through development and ultimately regulatory approval.
Led by a deeply experienced team of healthcare and investing professionals, the Fund is capitalized through philanthropic dollars to make investments in biotech companies. Our venture impact model then recycling returns into new investments, thereby extending the impact of its donors’ contributions.
SCOPE
The T1D Fund is seeking a Senior Associate to play a key role in sourcing, evaluating, and helping with the execution of investments, as well as supporting the management of the Fund’s current existing portfolio of ~25 active companies. The role provides a unique opportunity within life sciences venture capital to be part of a mission-driven venture impact fund driving new investment to further the mission of driving life-changing solutions for people living with type 1 diabetes (T1D).
The Fund invests across a range of modalities, clinical stages, and geographies developing innovative disease-modifying therapeutics relevant to the treatments, prevention, and cures in T1D. The Senior Associate will work closely with senior team members to lead investment processes end-to-end, engage with existing portfolio companies and new prospects, and contribute to the Fund’s strategic initiatives and thought leadership.
This position involves frequent interaction with external stakeholders across the biopharma, life sciences, and venture capital ecosystems. The role is based in Boston and follows hybrid work from office (generally, three days per week in office). The position will require occasional travel. The position is available immediately and has long-term potential for advancement within the T1D Fund. Salary range for this position is $175,000 to $225,000, commensurate with experience.
RESPONSIBILITIES
Drive scientific and business due diligence on investment opportunities in partnership with internal Breakthrough T1D staff and external experts.
Source new investment opportunities by analyzing scientific and market data, building industry relationships, and attending industry events.
Support portfolio company investments by coordinating interactions and conducting alliance management activities between the company, the T1D Fund, Breakthrough T1D, and external KOLs.
Build and maintain knowledge on scientific topics related to T1D including disease pathogenesis, pre-clinical models, existing and novel intervention targets, therapeutic modalities, and commonalities with related autoimmune or regenerative indications.
Build and maintain knowledge on drug development topics including clinical strategy, regulatory environment, competitive landscape, industry BD&L, clinical study readouts and other key developments.
Prepare and maintain internal documentation on potential investments, portfolio performance, and scientific and therapeutic landscapes related to T1D.
SKILLS & QUALIFICATIONS
2+ years prior experience in venture capital is required
Demonstrated passion for life sciences with an advanced degree in a relevant discipline (generally, a PhD and/or MD).
Must have a strong interest in working for a mission-driven, team-oriented organization.
Ability to work and exhibit leadership in a dynamic, fast-paced entrepreneurial environment.
Must be able to proactively prioritize competing demands and deliver high-quality results.
Exceptional written, verbal and interpersonal skills.
Experience in therapeutic areas related to T1D (immunology, metabolic disease, regenerative medicine, etc.) is a plus but not a requirement.